Fact CheckerSign in

NCT07197229Not yet recruiting

Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental Study at Assiut University

Evaluation of Three Months Combined Hospital and Home-Based Tailored Rehabilitation Program in COPD Patients Recently Admitted to Chest Department of Assiut University Hospital

Source: ClinicalTrials.gov · Last updated 29 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study evaluates the effect of a structured three-month pulmonary rehabilitation (PR) program, delivered both in-hospital and at home, on exercise capacity, respiratory symptoms, and functional status in stable COPD patients.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
20 Sept 2025
Start date
30 Apr 2026
Primary completion date
30 Oct 2027
Lead sponsor
Assiut University
Diseases
COPD
NCT number
NCT07197229

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 30 Apr 2026 to the primary completion date, 30 Oct 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Age \< 40 years
    • Current acute COPD exacerbation at enrollment
    • Significant comorbid conditions limiting participation (e.g., uncontrolled diabetes mellitus, uncontrolled hypertension, left-sided heart failure, renal failure, liver cell failure)
    • Neuromuscular diseases, severe cognitive impairment, or psychiatric disturbance
    • Pregnant patients
    • Unwilling to participate in the rehabilitation program

Who the study is looking for

  • Stable COPD patients diagnosed based on spirometry (post-bronchodilator FEV1/FVC \<70%)
    • Age \> 40 years
    • Moderate to severe COPD stage
    • Able and willing to participate in rehabilitation program

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.